Results 171 to 180 of about 65,460 (210)
Some of the next articles are maybe not open access.
2006
Systemic mastocytosis is a fascinating disease with diverse clinical features. There have been numerous advances in understanding the basis of clinical manifestations of this disease and of its molecular pathogenesis in the last several decades. The development of methods to study mast cell biology using cell culture and murine models has proven ...
Jamie, Robyn, Dean D, Metcalfe
openaire +2 more sources
Systemic mastocytosis is a fascinating disease with diverse clinical features. There have been numerous advances in understanding the basis of clinical manifestations of this disease and of its molecular pathogenesis in the last several decades. The development of methods to study mast cell biology using cell culture and murine models has proven ...
Jamie, Robyn, Dean D, Metcalfe
openaire +2 more sources
Eosinophilia in Systemic Mastocytosis
American Journal of Clinical Pathology, 1980The diagnosis of systemic mastocytosis depends on the proper recognition of extensive mast cells infiltration in tissues. Accurate identification of the mast cells in tissues may be difficult when there is no clinical suspicion to initiate a special search for these cells.
L T, Yam, C F, Yam, C Y, Li
openaire +2 more sources
The American Journal of Surgical Pathology, 1983
The clinical, radiologic, ultrastructural, and histopathologic findings in 14 patients with systemic mastocytosis were evaluated. Seven patients had evidence of urticaria pigmentosa (UP) and seven patients presented with no recognizable cutaneous lesions.
R D, Brunning +4 more
openaire +2 more sources
The clinical, radiologic, ultrastructural, and histopathologic findings in 14 patients with systemic mastocytosis were evaluated. Seven patients had evidence of urticaria pigmentosa (UP) and seven patients presented with no recognizable cutaneous lesions.
R D, Brunning +4 more
openaire +2 more sources
Treatment of Systemic Mastocytosis
Immunology and Allergy Clinics of North America, 2006It is an exciting time in the treatment of systemic mastocytosis. Major advances in the past 2 decades have helped to define the molecular abnormalities associated with this disease and to delineate pathways involved in its pathogenesis. This has directly translated into the development of novel targeted therapies. These therapies hold great promise to
Todd M, Wilson +2 more
openaire +2 more sources
MALIGNANT SYSTEMIC MASTOCYTOSIS
Australian and New Zealand Journal of Medicine, 1988Abstract:Malignant systemic mastocytosis is a rare disorder, a subgroup of the mast cell neoplasms. Its clinical and histological diagnosis is often difficult, especially in patients without cutaneous involvement. We report an unsuspected case who underwent laparotomy complicated by life‐threatening hypotension consistent with vasoactive mediator ...
S M, Jane, R, Sutherland, H H, Salem
openaire +2 more sources
Cimetidine in Systemic Mastocytosis
Drug Intelligence & Clinical Pharmacy, 1981A 54-year-old caucasian woman with systemic mastocytosis manifested by gastrointestinal and dermatological symptoms that were treated with cyproheptadine, Lomotil® (diphenoxylateatropine), and cimetidine was studied. The patient consented to discontinue the H 2 -receptor antagonist, and to ...
Mary J. Berg +3 more
openaire +2 more sources
[Systemic mastocytosis and malignant mastocytosis].
Presse medicale (Paris, France : 1983), 1990Systemic mastocytosis is a rare, often undiagnosed disease characterized by the proliferation of mast cells in several tissues. The clinical symptoms are related to the mast cell infiltrates, but also to the release of numerous mediators. Malignant mastocytosis is a term that refers to two different entities: aggressive mastocytosis, where the outcome ...
O, Lortholary +4 more
openaire +1 more source
DeckerMed Gastroenterology, Hepatology and Endoscopy, 2018
Systemic mastocytosis (SM) is a disease characterized by an abnormal proliferation and accumulation of a clonal population of mast cells in the tissues including the bone marrow, gastrointestinal tract, and skin. In the most common form, indolent mastocytosis, the symptoms are most often due to the consequences of mast cell activation and include ...
openaire +2 more sources
Systemic mastocytosis (SM) is a disease characterized by an abnormal proliferation and accumulation of a clonal population of mast cells in the tissues including the bone marrow, gastrointestinal tract, and skin. In the most common form, indolent mastocytosis, the symptoms are most often due to the consequences of mast cell activation and include ...
openaire +2 more sources
2016
Clinical History Image Findings Discussion Find Diagnosis Differential ...
openaire +1 more source
Clinical History Image Findings Discussion Find Diagnosis Differential ...
openaire +1 more source